Merit Medical Systems (MMSI) Expected to Post Quarterly Earnings on Thursday

Merit Medical Systems (NASDAQ:MMSI) is expected to issue its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect Merit Medical Systems to announce earnings of $0.96 per share and revenue of $405.2450 million for the quarter. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Individuals may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 4:30 PM ET.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The firm had revenue of $381.88 million for the quarter, compared to analyst estimates of $377.59 million. During the same quarter in the prior year, the firm earned $0.86 EPS. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, analysts expect Merit Medical Systems to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Merit Medical Systems Stock Performance

NASDAQ MMSI opened at $78.29 on Wednesday. Merit Medical Systems has a 52-week low of $59.74 and a 52-week high of $94.75. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 5.08. The company has a market capitalization of $4.67 billion, a P/E ratio of 33.89, a P/E/G ratio of 2.37 and a beta of 0.52. The company has a fifty day moving average of $68.73 and a 200-day moving average of $71.80.

Insiders Place Their Bets

In related news, Director Lynne N. Ward sold 5,000 shares of the stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total transaction of $313,050.00. Following the transaction, the director owned 7,809 shares of the company’s stock, valued at approximately $488,921.49. This trade represents a 39.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian G. Lloyd bought 2,000 shares of Merit Medical Systems stock in a transaction that occurred on Thursday, May 7th. The shares were acquired at an average cost of $62.62 per share, for a total transaction of $125,240.00. Following the acquisition, the insider owned 2,000 shares in the company, valued at $125,240. The trade was a ? increase in their position. The SEC filing for this purchase provides additional information. 0.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of MMSI. Lido Advisors LLC increased its holdings in shares of Merit Medical Systems by 3.8% during the fourth quarter. Lido Advisors LLC now owns 3,836 shares of the medical instruments supplier’s stock valued at $324,000 after acquiring an additional 140 shares in the last quarter. Maryland State Retirement & Pension System boosted its stake in Merit Medical Systems by 2.1% in the 4th quarter. Maryland State Retirement & Pension System now owns 8,693 shares of the medical instruments supplier’s stock worth $766,000 after purchasing an additional 180 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its stake in Merit Medical Systems by 0.4% in the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 50,667 shares of the medical instruments supplier’s stock worth $4,095,000 after purchasing an additional 189 shares in the last quarter. Cerity Partners LLC boosted its stake in Merit Medical Systems by 9.1% in the 2nd quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier’s stock worth $282,000 after purchasing an additional 251 shares in the last quarter. Finally, Wedbush Securities Inc. grew its position in Merit Medical Systems by 7.3% during the 4th quarter. Wedbush Securities Inc. now owns 3,983 shares of the medical instruments supplier’s stock worth $351,000 after purchasing an additional 271 shares during the last quarter. 99.66% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on MMSI shares. Piper Sandler reissued an “overweight” rating on shares of Merit Medical Systems in a research note on Friday, July 10th. Citigroup reaffirmed an “outperform” rating on shares of Merit Medical Systems in a research note on Monday, April 20th. Compass Point set a $107.00 price objective on Merit Medical Systems in a report on Monday, April 20th. Robert W. Baird set a $83.00 price objective on Merit Medical Systems in a research report on Friday, May 1st. Finally, Barrington Research decreased their price objective on Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating on the stock in a report on Monday, April 20th. Eight research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Merit Medical Systems has an average rating of “Moderate Buy” and an average target price of $92.80.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.